AECOM Technology Corporation (ACM) - FREE Research Report

Tishman Daniel R. who is Vice Chairman at AECOM Technology Corporation sold 30,000 shares at $31.03 on Oct. 11, 2013. Following this transaction, the Vice Chairman owned 389,277 shares meaning that the stake was reduced by 7.16% with the 30,000 share transaction.

The shares most recently traded at $31.06, up $0.03, or 0.1% since the insider transaction. Historical insider transactions for AECOM Technology Corporation go as follows:

  • 4-Week # shares sold: 27,975
  • 12-Week # shares bought: 1
  • 12-Week # shares sold: 127,975
  • 24-Week # shares bought: 1
  • 24-Week # shares sold: 547,847

The average volume for AECOM Technology Corporation has been 692,500 shares per day over the past 30 days. AECOM Technology Corporation has a market cap of $3.2 billion and is part of the services sector and diversified services industry. Shares are up 31.51% year to date as of the close of trading on Friday.

AECOM Technology Corporation, together with its subsidiaries, provides professional technical and management support services for commercial and government clients worldwide. Currently there are 6 analysts that rate AECOM Technology Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACM - FREE

TheStreet Quant Ratings rates AECOM Technology Corporation as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and poor profit margins. Get the full AECOM Technology Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal